natriumklorid baxter viaflo 9 mg/ml innrennslislyf, lausn 9 mg/ml
baxter medical ab* - sodium chloride - innrennslislyf, lausn - 9 mg/ml
eqvalan vet. pasta til inntöku 1,87 %
boehringer ingelheim animal health france scs - ivermectinum inn - pasta til inntöku - 1,87 %
glucos baxter viaflo 50 mg/ml innrennslislyf, lausn 50 mg/ml
baxter medical ab* - glucosum - innrennslislyf, lausn - 50 mg/ml
teriparatide sun
sun pharmaceutical industries europe b.v. - teriparatíð - osteoporosis; osteoporosis, postmenopausal - kalsíumsterastasis - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
eligard stungulyfsstofn og leysir, lausn 7,5 mg
recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 7,5 mg
warfarin teva tafla 1 mg
teva b.v.* - warfarinum natríum - tafla - 1 mg
eligard stungulyfsstofn og leysir, lausn 45 mg
recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 45 mg
eligard stungulyfsstofn og leysir, lausn 22,5 mg
recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 22,5 mg
plasmalyte glucos 50 mg/ml innrennslislyf, lausn 50 mg/ml
baxter medical ab* - glucosum; natrii chloridum; kalii chloridum; magnesii chloridum; natrii acetas; natrii gluconas - innrennslislyf, lausn - 50 mg/ml
warfarin teva tafla 3 mg
teva b.v.* - warfarinum natríum - tafla - 3 mg